Effects of recognizing depression with a standardized questionnaire (CES-D) versus patient reporting of depression after a single-standardized question on the outcomes of treatment for hepatitis C with pegylated interferon-α-2b and ribavirin

Frances H. Phillips, Melanie Prebis, Catherine Grumbeck, Teresa Hale, Raul Cubillas, Geri R. Brown

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Depression may worsen during antiviral treatment for hepatitis C virus, resulting in noncompliance treatment. AIM: The aim was to compare the response and compliance rates between the groups of veteran patients using two different methods of identifying depression, either the Centers for Epidemiology Studies for Depression Scale (group A) questionnaire or the report of symptoms of depression after a single-standardized question by the health care provider (group B). Methods: One hundred and twenty-nine patients were randomly assigned to the two groups before the treatment. Results: No statistical differences were noted in baseline characteristics between the groups. Depression was common in both the groups. No difference between initial Centers for Epidemiologic Studies Depression Scale scores and diagnosis of depression between the two groups was noted. Furthermore, the number of patients diagnosed with depression during the treatment was similar in each group. There were no significant differences between the groups in rates of sustained viral response (30% group A, 35% group B) or in rates of overall compliance with patients receiving more than 90% of prescribed PegIntronA therapy (44% group A, 39% group B), and ribavirin (32% group A and 37% group B). Conclusion: The use of the Centers for Epidemiology Studies for Depression Scale questionnaire to recognize depression had no significant advantage over patient reporting of depression symptoms after a single-standardized question on the hepatitis C virus clearance and the treatment compliance rates in veteran populations.

Original languageEnglish (US)
Pages (from-to)1435-1442
Number of pages8
JournalEuropean Journal of Gastroenterology and Hepatology
Volume22
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Ribavirin
Hepatitis C
Interferons
Depression
Veterans
Hepacivirus
Epidemiology
Surveys and Questionnaires
Therapeutics
Patient Compliance
Group Psychotherapy
Health Personnel
Antiviral Agents
Epidemiologic Studies

Keywords

  • depression
  • hepatitis C
  • pegylated interferon and ribavirin

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

@article{fbbabe7a6ba549639920a7a8c3e31790,
title = "Effects of recognizing depression with a standardized questionnaire (CES-D) versus patient reporting of depression after a single-standardized question on the outcomes of treatment for hepatitis C with pegylated interferon-α-2b and ribavirin",
abstract = "Background: Depression may worsen during antiviral treatment for hepatitis C virus, resulting in noncompliance treatment. AIM: The aim was to compare the response and compliance rates between the groups of veteran patients using two different methods of identifying depression, either the Centers for Epidemiology Studies for Depression Scale (group A) questionnaire or the report of symptoms of depression after a single-standardized question by the health care provider (group B). Methods: One hundred and twenty-nine patients were randomly assigned to the two groups before the treatment. Results: No statistical differences were noted in baseline characteristics between the groups. Depression was common in both the groups. No difference between initial Centers for Epidemiologic Studies Depression Scale scores and diagnosis of depression between the two groups was noted. Furthermore, the number of patients diagnosed with depression during the treatment was similar in each group. There were no significant differences between the groups in rates of sustained viral response (30{\%} group A, 35{\%} group B) or in rates of overall compliance with patients receiving more than 90{\%} of prescribed PegIntronA therapy (44{\%} group A, 39{\%} group B), and ribavirin (32{\%} group A and 37{\%} group B). Conclusion: The use of the Centers for Epidemiology Studies for Depression Scale questionnaire to recognize depression had no significant advantage over patient reporting of depression symptoms after a single-standardized question on the hepatitis C virus clearance and the treatment compliance rates in veteran populations.",
keywords = "depression, hepatitis C, pegylated interferon and ribavirin",
author = "Phillips, {Frances H.} and Melanie Prebis and Catherine Grumbeck and Teresa Hale and Raul Cubillas and Brown, {Geri R.}",
year = "2010",
month = "12",
doi = "10.1097/MEG.0b013e32833eb8c6",
language = "English (US)",
volume = "22",
pages = "1435--1442",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Effects of recognizing depression with a standardized questionnaire (CES-D) versus patient reporting of depression after a single-standardized question on the outcomes of treatment for hepatitis C with pegylated interferon-α-2b and ribavirin

AU - Phillips, Frances H.

AU - Prebis, Melanie

AU - Grumbeck, Catherine

AU - Hale, Teresa

AU - Cubillas, Raul

AU - Brown, Geri R.

PY - 2010/12

Y1 - 2010/12

N2 - Background: Depression may worsen during antiviral treatment for hepatitis C virus, resulting in noncompliance treatment. AIM: The aim was to compare the response and compliance rates between the groups of veteran patients using two different methods of identifying depression, either the Centers for Epidemiology Studies for Depression Scale (group A) questionnaire or the report of symptoms of depression after a single-standardized question by the health care provider (group B). Methods: One hundred and twenty-nine patients were randomly assigned to the two groups before the treatment. Results: No statistical differences were noted in baseline characteristics between the groups. Depression was common in both the groups. No difference between initial Centers for Epidemiologic Studies Depression Scale scores and diagnosis of depression between the two groups was noted. Furthermore, the number of patients diagnosed with depression during the treatment was similar in each group. There were no significant differences between the groups in rates of sustained viral response (30% group A, 35% group B) or in rates of overall compliance with patients receiving more than 90% of prescribed PegIntronA therapy (44% group A, 39% group B), and ribavirin (32% group A and 37% group B). Conclusion: The use of the Centers for Epidemiology Studies for Depression Scale questionnaire to recognize depression had no significant advantage over patient reporting of depression symptoms after a single-standardized question on the hepatitis C virus clearance and the treatment compliance rates in veteran populations.

AB - Background: Depression may worsen during antiviral treatment for hepatitis C virus, resulting in noncompliance treatment. AIM: The aim was to compare the response and compliance rates between the groups of veteran patients using two different methods of identifying depression, either the Centers for Epidemiology Studies for Depression Scale (group A) questionnaire or the report of symptoms of depression after a single-standardized question by the health care provider (group B). Methods: One hundred and twenty-nine patients were randomly assigned to the two groups before the treatment. Results: No statistical differences were noted in baseline characteristics between the groups. Depression was common in both the groups. No difference between initial Centers for Epidemiologic Studies Depression Scale scores and diagnosis of depression between the two groups was noted. Furthermore, the number of patients diagnosed with depression during the treatment was similar in each group. There were no significant differences between the groups in rates of sustained viral response (30% group A, 35% group B) or in rates of overall compliance with patients receiving more than 90% of prescribed PegIntronA therapy (44% group A, 39% group B), and ribavirin (32% group A and 37% group B). Conclusion: The use of the Centers for Epidemiology Studies for Depression Scale questionnaire to recognize depression had no significant advantage over patient reporting of depression symptoms after a single-standardized question on the hepatitis C virus clearance and the treatment compliance rates in veteran populations.

KW - depression

KW - hepatitis C

KW - pegylated interferon and ribavirin

UR - http://www.scopus.com/inward/record.url?scp=78349307327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349307327&partnerID=8YFLogxK

U2 - 10.1097/MEG.0b013e32833eb8c6

DO - 10.1097/MEG.0b013e32833eb8c6

M3 - Article

C2 - 20802340

AN - SCOPUS:78349307327

VL - 22

SP - 1435

EP - 1442

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 12

ER -